InMode Optimas
IPL multi-app platform · Platform hosting Lumecca + Diolaze + RF
Classification & configurations
Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)
At a glance
- New price
- $90k–$130kSource not documented
- Used asking price
- $40k–$70kSource not documented
- FDA status
- Supplies & recurring costs
- See supply and replacement costs below.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Read FDA-cleared indicationsExact wording from 5 FDA records
K123860 (Inmode MD, Ltd., 2013)
The InMode SR IPL Device wavelengths (515-l200nm) are indicated for use for the following treatments: " The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); " The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K170738 (Inmode MD, Ltd., 2017)
The InMode Diolaze XL System is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K173677 (Inmode MD, Ltd., 2018)
The InMode VLaze is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K151273 (Inmode MD, Ltd., 2016)
The InMode FRF Applicator is intended for use in Dermatologic and General Surgical procedures for Electrocoagulation and Hemostasis . At higher energy levels greater than 62 mJ/pin, use of the FRF applicator is limited to Skin Types I-IV.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K140926 (Inmode MD, Ltd., 2014)
The InMode WMface device is intended for use in dermatologic procedures for noninvasive treatment of mild to moderate facial wrinkles and rhytides.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: September 8, 2026 · How we verify
Axis runs $0–$130k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | InMode |
|---|---|
| Company | Owner: Publicly traded (NASDAQ: INMD; no single controlling owner) (public company, since 2019) · Distribution: direct |
| Parent company | InMode |
| Brand owner | InMode |
| Built by (OEM) | InMode Ltd. |
| Category | IPL multi-app platform |
| Technology | Platform hosting Lumecca + Diolaze + RF |
| FDA status | FDA Cleared |
| 510(k) citation | K123860, K170738, K173677, K151273, K140926 |
| New price range | $90k–$130k |
| Used asking range | $40k–$70k |
| Consumables | Not published |
| Launch year | 2017 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Workstation for IPL and diode HR
How it worksTechnology and manufacturing
How the technology works
A chassis powering interchangeable optical and RF handpieces. Lumecca is high-peak-power IPL (roughly 515/580nm cutoffs) targeting melanin and hemoglobin — sun damage, lentigines, rosacea, telangiectasia; InMode's pitch is higher peak power clears pigment in 1-2 sessions versus 3-5 for commodity IPLs.
Diolaze XL is a large-spot diode (810nm core; 755/810 and 810/1064 blends) for hair removal with contact cooling. Both non-invasive, no downtime.
Patented technology
Lumecca is branded high-peak-power IPL — a xenon flashlamp with tighter pulse control, not a new physics category. Diolaze XL's claim is one of the larger diode spots on the market plus built-in cooling — refined diode engineering.
Origin
Yokneam, Israel (InMode).
FDA & regulatory detailClearance timeline, authorization route and citation notes
Launch 2017 · Clearance 2018 · K123860; K170738; K173677; K151273; K140926
Platform clearance: FDA's device listing carries 'CONTOURA/OPTIMAS (system platform)' with the SR IPL/Lumecca (K123860, 2 Apr 2013), Diolaze XL (K170738, 7 Aug 2017), VLaze/Vasculaze (K173677, 23 Feb 2018), FRF/Fractora (K151273, 4 Jan 2016) and WMFace/Forma (K140926, 3 Dec 2014) applicators; no 510(k) naming Optimas was located (the 2025 Optimas MAX is a separate record, K251632). Checked 8 Sep 2026.
FDA-cleared indications (verbatim)
K123860 (Inmode MD, Ltd., 2013)
The InMode SR IPL Device wavelengths (515-l200nm) are indicated for use for the following treatments: " The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); " The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K170738 (Inmode MD, Ltd., 2017)
The InMode Diolaze XL System is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K173677 (Inmode MD, Ltd., 2018)
The InMode VLaze is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K151273 (Inmode MD, Ltd., 2016)
The InMode FRF Applicator is intended for use in Dermatologic and General Surgical procedures for Electrocoagulation and Hemostasis . At higher energy levels greater than 62 mJ/pin, use of the FRF applicator is limited to Skin Types I-IV.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K140926 (Inmode MD, Ltd., 2014)
The InMode WMface device is intended for use in dermatologic procedures for noninvasive treatment of mild to moderate facial wrinkles and rhytides.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
IPL multi-app platform — Platform hosting Lumecca + Diolaze + RF
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: InMode
Legal manufacturer: InMode Ltd. (Israel)
Applicant on the FDA record
InMode MD Ltd.The applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published InMode Optimas data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
ComplianceScreening and contraindications on the manufacturer's record
Contraindications & screening
Recent tanning or active melasma flare (IPL), pregnancy, photosensitizers, active infection/lesions in the field, keloid history, darker Fitzpatrick types on the 810-only handpiece.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History4 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 8, 2026
FDA status
Unknown → Cleared
Source: Record correction
September 8, 2026
FDA K-numbers
K123860; K170738; K173677; K151273; K140926
Source: Record correction
September 8, 2026
FDA source URL
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K123860
Source: Record correction
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "InMode Optimas — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.